Literature DB >> 1533068

Vaccines against schistosomiasis: where do we stand?

A E Butterworth1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1533068     DOI: 10.1016/0035-9203(92)90411-5

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


× No keyword cloud information.
  4 in total

1.  Induction of protective immunity against Schistosoma mansoni via DNA priming and boosting with the large subunit of calpain (Sm-p80): adjuvant effects of granulocyte-macrophage colony-stimulating factor and interleukin-4.

Authors:  Afzal A Siddiqui; Troy Phillips; Hugues Charest; Ron B Podesta; Martha L Quinlin; Justin R Pinkston; Jenny D Lloyd; Michelle Paz; Rachael M Villalovos; Janet Pompa
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

2.  Impaired immunity and altered pulmonary responses in mice with a disrupted interferon-gamma receptor gene exposed to the irradiated Schistosoma mansoni vaccine.

Authors:  R A Wilson; P S Coulson; C Betts; M A Dowling; L E Smythies
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

3.  Cloning, molecular characterization, and functional activity of Schistosoma japonicum glyceraldehyde-3-phosphate dehydrogenase, a putative vaccine candidate against schistosomiasis japonica.

Authors:  G J Waine; M Becker; W Yang; B Kalinna; D P McManus
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

Review 4.  Experimental vaccines in animal models for schistosomiasis.

Authors:  Afzal A Siddiqui; Gul Ahmad; Raymond T Damian; Ronald C Kennedy
Journal:  Parasitol Res       Date:  2008-02-08       Impact factor: 2.289

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.